Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Positive interim phase I/II data shown for Multikine in head and neck cancer

Aug. 9, 2000

Allovectin-7 phase I/II data released

Aug. 8, 2000

Beta LT meets safety goals early in clinical trials

Aug. 7, 2000

Trial set to test efficacy of bismuth-213-labeled monoclonal antibody in leukemia patients

Aug. 4, 2000

SciClone's Zadaxin prevents lung tumors in mouse model

Aug. 4, 2000

Clinicians urge review of the cardiotoxicity of trastuzumab

July 31, 2000

VRCTC-310-Onco enhances serum antiinflammatory cytokine production in humans

July 28, 2000

New allogeneic cancer vaccines in development at Onyvax

July 25, 2000

Genentech acquires rights to PSCA from UroGenesys

July 21, 2000

M-Vax now available in Australia for melanoma therapy

July 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....